These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 26218890)

  • 21. Dissociation of prion protein amyloid seeding from transmission of a spongiform encephalopathy.
    Piccardo P; King D; Telling G; Manson JC; Barron RM
    J Virol; 2013 Nov; 87(22):12349-56. PubMed ID: 24027305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein misfolding cyclic amplification (PMCA): Current status and future directions.
    Saá P; Cervenakova L
    Virus Res; 2015 Sep; 207():47-61. PubMed ID: 25445341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the local structural stabilities of mammalian prion protein (PrP) by fragment molecular orbital calculations.
    Hasegawa K; Mohri S; Yokoyama T
    Prion; 2013; 7(2):185-91. PubMed ID: 23232497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of infective property of recombinant prion protein amyloids in cultured cells overexpressing cellular prion protein.
    Kim DH; Lee HM; Ryou C
    J Korean Med Sci; 2014 Dec; 29(12):1604-9. PubMed ID: 25469058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular biology of prions causing infectious and genetic encephalopathies of humans as well as scrapie of sheep and BSE of cattle.
    Prusiner SB
    Dev Biol Stand; 1991; 75():55-74. PubMed ID: 1686599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amyloid formation by recombinant full-length prion proteins in phospholipid bicelle solutions.
    Lührs T; Zahn R; Wüthrich K
    J Mol Biol; 2006 Mar; 357(3):833-41. PubMed ID: 16466741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prion transmission prevented by modifying the β2-α2 loop structure of host PrPC.
    Kurt TD; Bett C; Fernández-Borges N; Joshi-Barr S; Hornemann S; Rülicke T; Castilla J; Wüthrich K; Aguzzi A; Sigurdson CJ
    J Neurosci; 2014 Jan; 34(3):1022-7. PubMed ID: 24431459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Probing the origin of prion protein misfolding via reconstruction of ancestral proteins.
    Cortez LM; Morrison AJ; Garen CR; Patterson S; Uyesugi T; Petrosyan R; Sekar RV; Harms MJ; Woodside MT; Sim VL
    Protein Sci; 2022 Dec; 31(12):e4477. PubMed ID: 36254680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The neuropathology of experimental bovine spongiform encephalopathy in the pig.
    Ryder SJ; Hawkins SA; Dawson M; Wells GA
    J Comp Pathol; 2000; 122(2-3):131-43. PubMed ID: 10684682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BSE: can we predict the future?
    Plum J
    Bull Mem Acad R Med Belg; 1997; 152(6):264-73. PubMed ID: 9581370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prion-like aggregates: infectious agents in human disease.
    Westermark GT; Westermark P
    Trends Mol Med; 2010 Nov; 16(11):501-7. PubMed ID: 20870462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Biology of non-conventional transmissible agents or prions].
    Dormont D
    Rev Neurol (Paris); 1998 Feb; 154(2):142-51. PubMed ID: 9773035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early detection of PrPres in BSE-infected bovine PrP transgenic mice.
    Castilla J; Gutiérrez Adán A; Brun A; Pintado B; Ramírez MA; Parra B; Doyle D; Rogers M; Salguero FJ; Sánchez C; Sánchez-Vizcaíno JM; Torres JM
    Arch Virol; 2003 Apr; 148(4):677-91. PubMed ID: 12664293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Silent prions lying in wait: a two-hit model of prion/amyloid formation and infection.
    Hall D; Edskes H
    J Mol Biol; 2004 Feb; 336(3):775-86. PubMed ID: 15095987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prion agent diversity and species barrier.
    Béringue V; Vilotte JL; Laude H
    Vet Res; 2008; 39(4):47. PubMed ID: 18519020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prions in skeletal muscle.
    Bosque PJ; Ryou C; Telling G; Peretz D; Legname G; DeArmond SJ; Prusiner SB
    Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3812-7. PubMed ID: 11904434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nucleic acid and prion protein interaction produces spherical amyloids which can function in vivo as coats of spongiform encephalopathy agent.
    Nandi PK; Nicole JC
    J Mol Biol; 2004 Nov; 344(3):827-37. PubMed ID: 15533448
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Structure of Mammalian Prions and Their Aggregates.
    Vázquez-Fernández E; Young HS; Requena JR; Wille H
    Int Rev Cell Mol Biol; 2017; 329():277-301. PubMed ID: 28109330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neutralizing Mutations Significantly Inhibit Amyloid Formation by Human Prion Protein and Decrease Its Cytotoxicity.
    Huang JJ; Li XN; Liu WL; Yuan HY; Gao Y; Wang K; Tang B; Pang DW; Chen J; Liang Y
    J Mol Biol; 2020 Feb; 432(4):828-844. PubMed ID: 31821812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Defining and Assessing Analytical Performance Criteria for Transmissible Spongiform Encephalopathy-Detecting Amyloid Seeding Assays.
    Gray JG; Graham C; Dudas S; Paxman E; Vuong B; Czub S
    J Mol Diagn; 2016 May; 18(3):454-467. PubMed ID: 27068712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.